MEGHAN GRONE: Open Payments
NPI 1174983555 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,034 in 45 payments from 10 companies in 2025. Trend: 2023 $1,027 · 2024 $710 · 2025 $1,034
Food & beverage: $1,034
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 11 | $382 |
| CVRx, Inc. | 15 | $185 |
| PFIZER INC. | 5 | $108 |
| Novartis Pharmaceuticals Corporation | 4 | $106 |
| Alnylam Pharmaceuticals Inc. | 2 | $71 |
| Invivyd Inc | 2 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $24 |
| AtriCure, Inc. | 1 | $22 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, Barostim Neo System, CARDIOMEMS, VYNDAQEL, LEQVIO, AMVUTTRA, PEMGARDA, JARDIANCE.
Industry payments across GA — which companies pay providers there.
